Product Information

QUDEXY XR 25 MG CAPSULE is a brand product labeled by Upsher-Smith Laboratories LLC, priced at $9.3250 per EA under NDC 00245107130. Its NADAC has been published 46 times since Feb 19, 2025.

QUDEXY XR 25 MG CAPSULE

Topiramate
$9.3250per EA

Strength

25 mg/1

NDC

00245107130

Classification

Brand

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Last Updated

4/23/2025

Active Ingredients

TOPIRAMATE

Approval Type

New Drug (NDA)

FDA Application

NDA205122

On Market Since

4/11/2014

Pharmacological Classes

Cytochrome P450 2C19 Inhibitors
Cytochrome P450 3A4 Inducers
Decreased Central Nervous System Disorganized Electrical Activity

Price Statistics

The NADAC for QUDEXY XR 25 MG CAPSULE has been published 46 times since Feb 19, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$9.3250 per EA
All-time high$9.3373 (Mar 12, 2025)
All-time low$9.3250 (Apr 23, 2025)
52-week high$9.3250
52-week low$9.3250
Median price$9.3250
Average price$9.3271
Largest weekly change-0.1% (Apr 23, 2025)
Weeks tracked46
Tracking sinceFeb 19, 2025

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

N/A

5Y

N/A

All

-0.1%

Generic Alternatives

The matcher finds 13 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 100% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of QUDEXY XR 25 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for QUDEXY XR 25 MG CAPSULE, manufactured by Upsher-Smith Laboratories LLC, is $9.3250 per EA (NDC 00245107130), effective Dec 31, 2025.

How has the price of QUDEXY XR 25 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for QUDEXY XR 25 MG CAPSULE has held within roughly two percent of its current level. It has been tracked across 46 weekly CMS publications since Feb 19, 2025.

What are the highest and lowest recorded NADAC prices for QUDEXY XR 25 MG CAPSULE?

Since Feb 19, 2025, the NADAC for QUDEXY XR 25 MG CAPSULE has ranged from a low of $9.3250 (Apr 23, 2025) to a high of $9.3373 (Mar 12, 2025), with a median of $9.3250 per EA.

Are there cheaper alternatives to QUDEXY XR 25 MG CAPSULE?

Yes. 13 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, TOPIRAMATE 25 MG TABLET, is $0.0254 per EA — about 100% below QUDEXY XR 25 MG CAPSULE.

Who manufactures QUDEXY XR 25 MG CAPSULE?

QUDEXY XR 25 MG CAPSULE (NDC 00245107130) is labeled by Upsher-Smith Laboratories LLC, and CMS classifies it as a brand product.